Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TFEB gene therapy
- Development stage
- Preclinical
- Lead developer
- Coave Therapeutics
- Modality
- Gene Therapies
- Administration
- Intravenous, Intrathecal
01
Overview
TFEB gene therapy is a regenerative medicine intervention offered by Integrated Healthcare Systems designed to address age-related proteostasis decline and various neurodegenerative or metabolic conditions. The therapy utilizes gene delivery to upregulate the expression or activity of Transcription Factor EB (TFEB), a master regulator of lysosomal biogenesis and the autophagy pathway. By activating the Coordinated Lysosomal Expression and Regulation (CLEAR) network, the treatment aims to enhance the cell's ability to degrade misfolded proteins, damaged organelles, and lipid aggregates. This approach is intended to restore cellular homeostasis and counteract the pathological accumulation of toxic cellular waste associated with aging and chronic disease. It is currently offered as a concierge medical service rather than through traditional regulated clinical trial phases.
- Other names
- TFEB activationTFEB-mediated autophagy inductionTranscription factor EB gene therapy
02
Targets
DNA
Beyond the preview
Go deeper on TFEB gene therapy.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TFEB gene therapy.